Shandong Wohua Pharmaceutical (002107) Stock Overview

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers tablets, hard capsules, granules, powders, and pills, such as honeyed, water, and concentrated pills. The company also produces and sells oral liquids, mixtures, liquors, tinctures, decoctions, and syrups, as well as patent medicines; and provides medical technology consulting services. Its products include drugs for cardiovascular and cerebrovascular diseases, such as Wohua Xinkeshu tablets, Holdan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gushukang capsules/granules, Yuandu Hanbi liquid, and Kite cold paralysis medicine liquor; Amber hydrazine particles for urinary system diseases; Pediatric Antipyretic granules for pediatric medicine; Anti-ginseng anti-itch particles for skin diseases; and Echinacea capsules for digestive and gynecological diseases, as well as Siyu Yangxue Yishen granules. The company was founded in 2003 and is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment Group Co., Ltd.